CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.

TitleCD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.
Publication TypeJournal Article
Year of Publication2006
AuthorsMartin DL, D Weatherly B, Laucella SA, Cabinian MA, Crim MT, Sullivan S, Heiges M, Craven SH, Rosenberg CS, Collins MH, Sette A, Postan M, Tarleton RL
JournalPLoS Pathog
Volume2
Issue8
Paginatione77
Date Published2006 Aug
ISSN1553-7374
KeywordsAdult, Animals, Argentina, Brazil, CD8-Positive T-Lymphocytes, Cells, Cultured, Chagas Disease, Cytotoxicity, Immunologic, Disease Models, Animal, Genetic Variation, Genome, Humans, Isoenzymes, Major Histocompatibility Complex, Mice, Mice, Inbred C57BL, Neuraminidase, Trypanosoma cruzi
Abstract

CD8+ T cells are crucial for control of a number of medically important protozoan parasites, including Trypanosoma cruzi, the agent of human Chagas disease. Yet, in contrast to the wealth of information from viral and bacterial infections, little is known about the antigen specificity or the general development of effector and memory T-cell responses in hosts infected with protozoans. In this study we report on a wide-scale screen for the dominant parasite peptides recognized by CD8+ T cells in T. cruzi-infected mice and humans. This analysis demonstrates that in both hosts the CD8+ T-cell response is highly focused on epitopes encoded by members of the large trans-sialidase family of genes. Responses to a restricted set of immunodominant peptides were especially pronounced in T. cruzi-infected mice, with more than 30% of the CD8+ T-cell response at the peak of infection specific for two major groups of trans-sialidase peptides. Experimental models also demonstrated that the dominance patterns vary depending on the infective strain of T. cruzi, suggesting that immune evasion may be occurring at a population rather than single-parasite level.

DOI10.1371/journal.ppat.0020077
Alternate JournalPLoS Pathog.
PubMed ID16879036
PubMed Central IDPMC1526708
Grant ListR01 AI022070 / AI / NIAID NIH HHS / United States
AI-033106 / AI / NIAID NIH HHS / United States
P01 AI044979 / AI / NIAID NIH HHS / United States
AI-044979 / AI / NIAID NIH HHS / United States
R01 AI033106 / AI / NIAID NIH HHS / United States
AI-022070 / AI / NIAID NIH HHS / United States

Person Type: